Singulair

Merck's Struggles To Replace Singulair Lead To Biosimilars

Merck's Struggles To Replace Singulair Lead To Biosimilars

Seeking Alpha

Merck's Crash of a Titan

Merck's Crash of a Titan

Motley Fool

Merck - How To Play This 'Patent Cliff' With Options

Merck - How To Play This 'Patent Cliff' With Options

Seeking Alpha

5 Things to Watch This Week in the Health-Care Sector

5 Things to Watch This Week in the Health-Care Sector

Motley Fool

Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules

Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules

Enhanced Online News

Trading Merck Ahead of the Patent Cliff

Trading Merck Ahead of the Patent Cliff

Motley Fool

Prescriptions for Merck's Singulair Plunge After Loss of U.S. Patent

Prescriptions for Merck's Singulair Plunge After Loss of U.S. Patent

NASDAQ.com

Mylan Waits Patiently at the Bottom of the Patent Cliff

Mylan Waits Patiently at the Bottom of the Patent Cliff

Motley Fool

US FDA approves first generic versions of Merck's Singulair

US FDA approves first generic versions of Merck's Singulair

Reuters

Merck: Can 5 New Drugs Fill Singulair Gap?

Merck: Can 5 New Drugs Fill Singulair Gap?

Seeking Alpha